Why Castle Biosciences Stock Is Jumping Today
The nice gain came after the genetic testing company announced its second-quarter results following the market close on Wednesday. Castle reported Q2 revenue of $50 million, a year-over-year (YOY) increase of 44%. The company posted a net loss in the second quarter of $18.8 million, or $0.70 per share.